Internal Medicine, Hematology & Oncology · Corpus Christi, TX
NPI
1952305591
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
7121 S Padre Island Dr, Suite 102-101,119
Corpus Christi, TX, 78412
Phone (361) 696-6000
Groups this clinician bills Medicare through
Medicare paid, 2024
$5.6M
347,170 services
Medicare patients, 2024
816
Average age 75
Drug cost, 2024
$12.1M
4,912 prescriptions
Company payments, 2025
$5,924
From 55 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Aftab Mahmood was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 60,690 times for 60 patients. In total Aftab Mahmood billed 347,170 services in 138 codes, and Medicare paid $5.6M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-23.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 60,690 | 60 | $0.27 | $17K |
| J0897 Injection, denosumab, 1 mg | Office | 28,560 | 189 | $20.33 | $581K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 24,800 | 19 | $44.07 | $1.1M |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 21,210 | 19 | $8.59 | $182K |
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 18,000 | 16 | $0.83 | $15K |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 14,360 | 31 | $6.36 | $91K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 9,750 | 18 | $0.11 | $1,106 |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 4,500 | 31 | $14.77 | $66K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,591 | 56 | $0.09 | $322 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 2,740 | 42 | $0.73 | $1,990 |
| 96372 Injection Administration | Office | 1,241 | 276 | $9.88 | $12K |
| Q5108 Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg | Office | 1,188 | 22 | $113.39 | $135K |
| 99214 Office E&M - Established | Office | 810 | 482 | $89.10 | $72K |
| 96367 Intravenous Infusion, Hydration | Office | 786 | 99 | $20.19 | $16K |
| 96413 Chemotherapy Administration | Office | 613 | 92 | $89.56 | $55K |
By year: 2022 $5.5M for 359,923 services; 2023 $4.6M for 341,622 services; 2024 $5.6M for 347,170 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 45 | 15 | $3.41 | $153 |
Medicare prescription drug claims, 2024
In 2024, the drug Aftab Mahmood prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 195 prescriptions and refills. In total Aftab Mahmood wrote 4,912 Medicare prescriptions that cost $12.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 195 | 198 | 49 | $9,176 |
| Exemestane Generic | 184 | 387 | 61 | $28K |
| Ondansetron Odt Ondansetron | 161 | 162 | 129 | $3,853 |
| Dexamethasone Generic | 154 | 176 | 74 | $4,314 |
| Letrozole Generic | 151 | 372 | 44 | $3,634 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 119 | 119 | 96 | $1,484 |
| Famciclovir Generic | 117 | 201 | 31 | $8,049 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 109 | 173 | 29 | $640 |
| Prochlorperazine Maleate Generic | 108 | 108 | 78 | $2,671 |
| Prednisone Generic | 106 | 152 | 38 | $839 |
| Gabapentin Generic | 94 | 118 | 33 | $1,439 |
| Ibrance Palbociclib | 93 | 93 | 11 | $1.3M |
| Granisetron Hcl Generic | 89 | 89 | 75 | $12K |
| Loperamide Loperamide Hcl | 86 | 91 | 67 | $1,248 |
| Hydroxyurea Generic | 80 | 205 | 28 | $2,783 |
Brand drugs: - claims; generic drugs: 3,890 claims; opioid claims: 349.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Aftab Mahmood $5,924 ($5,924 in general payments such as food, travel and fees) from 55 companies. The largest payer was Janssen Biotech, Inc. with $745.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 32 | $745 |
| Novartis Pharmaceuticals Corporation NVS | 27 | $540 |
| AstraZeneca Pharmaceuticals LP AZN | 13 | $339 |
| Merck Sharp & Dohme LLC MRK | 11 | $284 |
| Jazz Pharmaceuticals Inc. JAZZ | 6 | $245 |
| E.R. Squibb & Sons, L.L.C. BMY | 15 | $242 |
| Eisai Inc. 4523.T | 14 | $241 |
| Karyopharm Therapeutics Inc. KPTI | 9 | $181 |
| GlaxoSmithKline, LLC. GSK | 11 | $180 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 9 | $161 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.